Clinical Impact of APS Selection, Analytical Performance Specifications, in the Diagnosis and Monitoring of Renal Profile

Abstract

Chronic kidney disease (CKD) is one of the rapidly growing kidney complications in U. S. citizens. The purpose of this study is to affect the calculation of the sigma metric in laboratory settings based on the analytical performance specification (APS), given its influence. In our investigation, we look into various levels of APS and their impact on different test performance metrics. The findings suggest that the appropriate sigma metric calculation emphasizes the laboratory test quality as it is within the laboratory performing the tests. Laboratory performance metrics are key for achieving the testing’s precision, accuracy, and control standards. The diagnostic accuracy and reliability depend on how optimally APS values are selected relative to clinically significant target values. This study aims to underscore selectively tailored APS values for clinically specified targets so that not only accuracy but also precision of diagnostics is achieved. Laboratory practices and patient safety are improved by underscoring APS’s involvement in sigma metric calculations as a control improvement strategy. It was noted that selecting APS needs integration into the logic of planning clinical laboratory quality management systems